Dr Reddys Laboratories has received the approval of the National Company Law Tribunal NCLT Hyderabad Bench for the scheme of amalgamation of Dr Reddys Holdings an entity held by the Promoter Group which holds 2483Percentage equity shares of Dr Reddys Laboratories into the Company The scheme was approved on 05 April 2022 and the order was uploaded on the NCLT website on 07 April 2022
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
